USPTO serial 86913642
M
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SHINER, MARK W
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with M?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Quebec (Quebec), CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for treatment of infectious diseases, chronic diseases and cancer | ACTIVE | — |
| 040 | Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for others | ACTIVE | — |
| 042 | Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; medical and scientific research regarding clinical trial studies on new vaccine candidates; development of pharmaceuticals, pharmaceutical ingredients, vaccines, and antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 19, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 19, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 21, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 21, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 21, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 21, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 21, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 21, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 26, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 26, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 26, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 24, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 24, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 24, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 24, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 11, 2016 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 11, 2016 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 11, 2016 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 11, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 11, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 11, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 11, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2016 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Feb 25, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2016 | NWAP | NEW APPLICATION ENTERED | — |